Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 702

1.

Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.

Quattrone A, Morelli M, Vescio B, Nigro S, Le Piane E, Sabatini U, Caracciolo M, Vescio V, Quattrone A, Barbagallo G, Stanà C, Nicoletti G, Arabia G, Nisticò R, Novellino F, Salsone M.

Mov Disord. 2019 Feb 13. doi: 10.1002/mds.27621. [Epub ahead of print]

PMID:
30759325
2.

Methodologies of speech analysis for neurodegenerative diseases evaluation.

Vizza P, Tradigo G, Mirarchi D, Bossio RB, Lombardo N, Arabia G, Quattrone A, Veltri P.

Int J Med Inform. 2019 Feb;122:45-54. doi: 10.1016/j.ijmedinf.2018.11.008. Epub 2018 Nov 26.

PMID:
30623783
3.

Cerebrospinal Fluid Pressure-Related Features in Chronic Headache: A Prospective Study and Potential Diagnostic Implications.

Bono F, Curcio M, Rapisarda L, Vescio B, Bombardieri C, Mangialavori D, Aguglia U, Quattrone A.

Front Neurol. 2018 Dec 18;9:1090. doi: 10.3389/fneur.2018.01090. eCollection 2018.

4.

Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery.

D'Agostino VG, Sighel D, Zucal C, Bonomo I, Micaelli M, Lolli G, Provenzani A, Quattrone A, Adami V.

SLAS Discov. 2019 Mar;24(3):314-331. doi: 10.1177/2472555218818065. Epub 2019 Jan 7.

PMID:
30616427
5.

In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.

Barbagallo G, Morelli M, Quattrone A, Chiriaco C, Vaccaro MG, Gullà D, Rocca F, Caracciolo M, Novellino F, Sarica A, Arabia G, Sabatini U, Quattrone A.

Parkinsonism Relat Disord. 2018 Dec 11. pii: S1353-8020(18)30536-4. doi: 10.1016/j.parkreldis.2018.12.008. [Epub ahead of print]

PMID:
30558837
6.

Track density imaging in progressive supranuclear palsy: A pilot study.

Nigro S, Bianco MG, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Augimeri A, Quattrone A.

Hum Brain Mapp. 2018 Nov 26. doi: 10.1002/hbm.24484. [Epub ahead of print]

PMID:
30474903
7.

Editorial: Precision Medicine in Oncology.

Re A, Nardella C, Quattrone A, Lunardi A.

Front Oncol. 2018 Oct 26;8:479. doi: 10.3389/fonc.2018.00479. eCollection 2018. No abstract available.

8.

Gender difference and correlation between sexuality, thyroid hormones, cognitive, and physical functions in elderly fit.

Emerenziani GP, Izzo G, Vaccaro MG, Quattrone A, Lenzi A, Aversa A.

J Endocrinol Invest. 2018 Nov 7. doi: 10.1007/s40618-018-0974-1. [Epub ahead of print]

PMID:
30406377
9.

Active Ribosome Profiling with RiboLace.

Clamer M, Tebaldi T, Lauria F, Bernabò P, Gómez-Biagi RF, Marchioretto M, Kandala DT, Minati L, Perenthaler E, Gubert D, Pasquardini L, Guella G, Groen EJN, Gillingwater TH, Quattrone A, Viero G.

Cell Rep. 2018 Oct 23;25(4):1097-1108.e5. doi: 10.1016/j.celrep.2018.09.084.

10.

The hnRNP raly regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.

Gasperini L, Rossi A, Cornella N, Peroni D, Zuccotti P, Potrich V, Quattrone A, Macchi P.

Mol Biol Cell. 2018 Oct 24:mbcE18020108. doi: 10.1091/mbc.E18-02-0108. [Epub ahead of print]

PMID:
30354839
11.

Was the subject portrayed in "A Man" by Cornelis Anthonisz around 1530 really affected by progressive supranuclear palsy?

Morelli M, Quattrone A.

Neurol Sci. 2019 Feb;40(2):427-428. doi: 10.1007/s10072-018-3600-2. Epub 2018 Oct 15. No abstract available.

PMID:
30324250
12.

The application of artificial intelligence to understand the pathophysiological basis of psychogenic nonepileptic seizures.

Vasta R, Cerasa A, Sarica A, Bartolini E, Martino I, Mari F, Metitieri T, Quattrone A, Gambardella A, Guerrini R, Labate A.

Epilepsy Behav. 2018 Oct;87:167-172. doi: 10.1016/j.yebeh.2018.09.008. Epub 2018 Sep 28.

13.

Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.

Quattrone A, Barbagallo G, Cerasa A, Stoessl AJ.

Mov Disord. 2018 Aug;33(8):1213-1227. doi: 10.1002/mds.27438. Review.

PMID:
30230624
14.

MRI Asymmetry Index of Hippocampal Subfields Increases Through the Continuum From the Mild Cognitive Impairment to the Alzheimer's Disease.

Sarica A, Vasta R, Novellino F, Vaccaro MG, Cerasa A, Quattrone A; Alzheimer's Disease Neuroimaging Initiative.

Front Neurosci. 2018 Aug 21;12:576. doi: 10.3389/fnins.2018.00576. eCollection 2018.

15.

Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice.

Filipescu IE, Leonardi L, Menchetti L, Guelfi G, Traina G, Casagrande-Proietti P, Piro F, Quattrone A, Barbato O, Brecchia G.

PLoS One. 2018 Aug 23;13(8):e0202929. doi: 10.1371/journal.pone.0202929. eCollection 2018.

16.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.

PMID:
30068492
17.

Exoskeleton-Robot Assisted Therapy in Stroke Patients: A Lesion Mapping Study.

Cerasa A, Pignolo L, Gramigna V, Serra S, Olivadese G, Rocca F, Perrotta P, Dolce G, Quattrone A, Tonin P.

Front Neuroinform. 2018 Jul 17;12:44. doi: 10.3389/fninf.2018.00044. eCollection 2018.

18.

Analysis of the TMEM230 gene in patients with multiple system atrophy.

Procopio R, Gagliardi M, Brighina L, Nicoletti G, Morelli M, Piatti M, Annesi G, Quattrone A.

J Neurol Sci. 2018 Sep 15;392:128-129. doi: 10.1016/j.jns.2018.07.019. Epub 2018 Jul 23. No abstract available.

PMID:
30056200
19.

Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.

J Neurol. 2018 Oct;265(10):2243-2250. doi: 10.1007/s00415-018-8980-y. Epub 2018 Jul 26.

PMID:
30051273
20.

HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA.

Tebaldi T, Zuccotti P, Peroni D, Köhn M, Gasperini L, Potrich V, Bonazza V, Dudnakova T, Rossi A, Sanguinetti G, Conti L, Macchi P, D'Agostino V, Viero G, Tollervey D, Hüttelmaier S, Quattrone A.

Mol Cell. 2018 Jul 19;71(2):256-270.e10. doi: 10.1016/j.molcel.2018.06.032.

21.

Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data.

Saccà V, Sarica A, Novellino F, Barone S, Tallarico T, Filippelli E, Granata A, Chiriaco C, Bruno Bossio R, Valentino P, Quattrone A.

Brain Imaging Behav. 2018 Jul 11. doi: 10.1007/s11682-018-9926-9. [Epub ahead of print]

PMID:
29992392
22.

DNAJC13 mutation screening in patients with Parkinson's disease from South Italy.

Gagliardi M, Annesi G, Procopio R, Morelli M, Iannello G, Bonapace G, Mancini M, Nicoletti G, Quattrone A.

Parkinsonism Relat Disord. 2018 Oct;55:134-137. doi: 10.1016/j.parkreldis.2018.06.004. Epub 2018 Jun 4.

PMID:
29887357
23.

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Arabia G, Lupo A, Manfredini LI, Vescio B, Nisticò R, Barbagallo G, Salsone M, Morelli M, Novellino F, Nicoletti G, Quattrone A, Cascini GL, Louis ED, Quattrone A.

Parkinsonism Relat Disord. 2018 Nov;56:20-26. doi: 10.1016/j.parkreldis.2018.06.005. Epub 2018 Jun 5.

PMID:
29885986
24.

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.

Liang Y, Tebaldi T, Rejeski K, Joshi P, Stefani G, Taylor A, Song Y, Vasic R, Maziarz J, Balasubramanian K, Ardasheva A, Ding A, Quattrone A, Halene S.

Leukemia. 2018 Dec;32(12):2659-2671. doi: 10.1038/s41375-018-0152-7. Epub 2018 Jun 1.

25.

Mutational analysis of TARDBP gene in patients affected by Parkinson's disease from Calabria.

Gagliardi M, Arabia G, Nisticò R, Iannello G, Procopio R, Manfredini L, Annesi G, Quattrone A.

J Neurol Sci. 2018 Jul 15;390:209-211. doi: 10.1016/j.jns.2018.04.043. Epub 2018 May 1.

PMID:
29801890
26.

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

Aveic S, Pantile M, Polo P, Sidarovich V, De Mariano M, Quattrone A, Longo L, Tonini GP.

Cancer Cell Int. 2018 Apr 24;18:63. doi: 10.1186/s12935-018-0557-4. eCollection 2018.

27.

Midbrain meningioma causing subacute parkinsonism.

Labate A, Nisticò R, Cherubini A, Quattrone A.

Neurol Clin Pract. 2018 Apr;8(2):166-168. doi: 10.1212/CPJ.0000000000000439. No abstract available.

PMID:
29708227
28.

A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.

Sidarovich V, De Mariano M, Aveic S, Pancher M, Adami V, Gatto P, Pizzini S, Pasini L, Croce M, Parodi F, Cimmino F, Avitabile M, Emionite L, Cilli M, Ferrini S, Pagano A, Capasso M, Quattrone A, Tonini GP, Longo L.

Mol Cancer Ther. 2018 Jul;17(7):1405-1415. doi: 10.1158/1535-7163.MCT-17-0841. Epub 2018 Apr 25.

PMID:
29695637
29.

Positioning Europe for the EPITRANSCRIPTOMICS challenge.

Jantsch MF, Quattrone A, O'Connell M, Helm M, Frye M, Macias-Gonzales M, Ohman M, Ameres S, Willems L, Fuks F, Oulas A, Vanacova S, Nielsen H, Bousquet-Antonelli C, Motorin Y, Roignant JY, Balatsos N, Dinnyes A, Baranov P, Kelly V, Lamm A, Rechavi G, Pelizzola M, Liepins J, Holodnuka Kholodnyuk I, Zammit V, Ayers D, Drablos F, Dahl JA, Bujnicki J, Jeronimo C, Almeida R, Neagu M, Costache M, Bankovic J, Banovic B, Kyselovic J, Valor LM, Selbert S, Pir P, Demircan T, Cowling V, Schäfer M, Rossmanith W, Lafontaine D, David A, Carre C, Lyko F, Schaffrath R, Schwartz S, Verdel A, Klungland A, Purta E, Timotijevic G, Cardona F, Davalos A, Ballana E, O Carroll D, Ule J, Fray R.

RNA Biol. 2018;15(6):829-831. doi: 10.1080/15476286.2018.1460996. Epub 2018 May 9.

30.

Hydrogen peroxide is a neuronal alarmin that triggers specific RNAs, local translation of Annexin A2, and cytoskeletal remodeling in Schwann cells.

Negro S, Stazi M, Marchioretto M, Tebaldi T, Rodella U, Duregotti E, Gerke V, Quattrone A, Montecucco C, Rigoni M, Viero G.

RNA. 2018 Jul;24(7):915-925. doi: 10.1261/rna.064816.117. Epub 2018 Apr 11.

31.

Antidepressant-like actions by silencing of neuronal ELAV-like RNA-binding proteins HuB and HuC in a model of depression in male mice.

Sanna MD, Quattrone A, Galeotti N.

Neuropharmacology. 2018 Jun;135:444-454. doi: 10.1016/j.neuropharm.2018.04.001. Epub 2018 Apr 5.

PMID:
29626565
32.

Editorial on special issue: Machine learning on MCI.

Sarica A, Cerasa A, Quattrone A, Calhoun V.

J Neurosci Methods. 2018 May 15;302:1-2. doi: 10.1016/j.jneumeth.2018.03.011. Epub 2018 Mar 23. No abstract available.

PMID:
29581008
33.

The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.

Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasà M, Quattrone A, Bianco MG, Morelli M, Augimeri A, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jul;52:17-23. doi: 10.1016/j.parkreldis.2018.03.012. Epub 2018 Mar 14.

PMID:
29551396
34.

Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.

Thongon N, Zucal C, D'Agostino VG, Tebaldi T, Ravera S, Zamporlini F, Piacente F, Moschoi R, Raffaelli N, Quattrone A, Nencioni A, Peyron JF, Provenzani A.

Cancer Metab. 2018 Mar 8;6:1. doi: 10.1186/s40170-018-0174-7. eCollection 2018.

35.
36.

Cardiac parasympathetic index identifies subjects with adult obstructive sleep apnea: A simultaneous polysomnographic-heart rate variability study.

Salsone M, Vescio B, Quattrone A, Roccia F, Sturniolo M, Bono F, Aguglia U, Gambardella A, Quattrone A.

PLoS One. 2018 Mar 8;13(3):e0193879. doi: 10.1371/journal.pone.0193879. eCollection 2018.

37.

Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.

Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S, Filippelli E, Demonte G, Polidoro S, Granata A, Scannapieco S, Quinto I, Valentino P, Quattrone A.

FASEB J. 2018 Aug;32(8):4241-4246. doi: 10.1096/fj.201701533R. Epub 2018 Mar 5.

PMID:
29505299
38.

Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease.

Piro A, Tagarelli A, Nicoletti G, Scannapieco S, Polidoro S, Valentino P, Quattrone A.

Int Ophthalmol. 2018 Feb 1. doi: 10.1007/s10792-018-0838-x. [Epub ahead of print]

PMID:
29392642
39.

Physiological Aging Influence on Brain Hemodynamic Activity during Task-Switching: A fNIRS Study.

Vasta R, Cutini S, Cerasa A, Gramigna V, Olivadese G, Arabia G, Quattrone A.

Front Aging Neurosci. 2018 Jan 8;9:433. doi: 10.3389/fnagi.2017.00433. eCollection 2017.

40.

Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study.

Labate A, Mumoli L, Curcio A, Tripepi G, D'Arrigo G, Ferlazzo E, Aguglia U, Indolfi C, Quattrone A, Gambardella A.

Eur J Neurol. 2018 May;25(5):711-717. doi: 10.1111/ene.13579. Epub 2018 Mar 1. Erratum in: Eur J Neurol. 2018 Oct;25(10):1303.

PMID:
29359374
41.

Relationship between Hippocampal Subfields and Category Cued Recall in AD and PDD: A Multimodal MRI Study.

Novellino F, Vasta R, Sarica A, Chiriaco C, Salsone M, Morelli M, Arabia G, Saccà V, Nicoletti G, Quattrone A.

Neuroscience. 2018 Feb 10;371:506-517. doi: 10.1016/j.neuroscience.2017.12.028. Epub 2017 Dec 29.

PMID:
29292073
42.

Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment.

Barone S, Scannapieco S, Torti C, Filippelli E, Pisani V, Granata A, Console D, Demonte G, Tallarico T, Polidoro S, Quattrone A, Valentino P.

Mult Scler Relat Disord. 2018 Feb;20:6-8. doi: 10.1016/j.msard.2017.12.009. Epub 2017 Dec 18.

PMID:
29272733
43.

Corrigendum to "A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy" [J. Neurol. Sci. 381C (2017) 209-212].

Iannello G, Graziano C, Cenacchi G, Cordelli DM, Zuntini R, Papa V, Magistà AM, Gagliardi M, Procopio R, Quattrone A, Annesi G.

J Neurol Sci. 2018 Feb 15;385:238. doi: 10.1016/j.jns.2017.12.002. Epub 2017 Dec 15. No abstract available.

PMID:
29254810
44.

A new CHCHD2 mutation identified in a southern italy patient with multiple system atrophy.

Nicoletti G, Gagliardi M, Procopio R, Iannello G, Morelli M, Annesi G, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:91-93. doi: 10.1016/j.parkreldis.2017.12.005. Epub 2017 Dec 7. No abstract available.

PMID:
29248339
45.

Color vision as a biological marker able to differentiate two phenotypically similar neurological diseases.

Piro A, Tagarelli A, Nicoletti G, Chiriaco C, Novellino F, Quattrone A.

Neurol Sci. 2018 May;39(5):951-952. doi: 10.1007/s10072-017-3219-8. Epub 2017 Dec 14. No abstract available.

PMID:
29242999
46.

Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.

Barbagallo G, Arabia G, Novellino F, Nisticò R, Salsone M, Morelli M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:57-63. doi: 10.1016/j.parkreldis.2017.11.345. Epub 2017 Nov 28.

PMID:
29203059
47.

TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy.

Aveic S, Corallo D, Porcù E, Pantile M, Boso D, Zanon C, Viola G, Sidarovich V, Mariotto E, Quattrone A, Basso G, Tonini GP.

Eur J Pharmacol. 2018 Jan 5;818:435-448. doi: 10.1016/j.ejphar.2017.11.016. Epub 2017 Nov 14.

PMID:
29154838
48.

The challenge of mapping the human connectome based on diffusion tractography.

Maier-Hein KH, Neher PF, Houde JC, Côté MA, Garyfallidis E, Zhong J, Chamberland M, Yeh FC, Lin YC, Ji Q, Reddick WE, Glass JO, Chen DQ, Feng Y, Gao C, Wu Y, Ma J, Renjie H, Li Q, Westin CF, Deslauriers-Gauthier S, González JOO, Paquette M, St-Jean S, Girard G, Rheault F, Sidhu J, Tax CMW, Guo F, Mesri HY, Dávid S, Froeling M, Heemskerk AM, Leemans A, Boré A, Pinsard B, Bedetti C, Desrosiers M, Brambati S, Doyon J, Sarica A, Vasta R, Cerasa A, Quattrone A, Yeatman J, Khan AR, Hodges W, Alexander S, Romascano D, Barakovic M, Auría A, Esteban O, Lemkaddem A, Thiran JP, Cetingul HE, Odry BL, Mailhe B, Nadar MS, Pizzagalli F, Prasad G, Villalon-Reina JE, Galvis J, Thompson PM, Requejo FS, Laguna PL, Lacerda LM, Barrett R, Dell'Acqua F, Catani M, Petit L, Caruyer E, Daducci A, Dyrby TB, Holland-Letz T, Hilgetag CC, Stieltjes B, Descoteaux M.

Nat Commun. 2017 Nov 7;8(1):1349. doi: 10.1038/s41467-017-01285-x.

49.

Personality biomarkers of pathological gambling: A machine learning study.

Cerasa A, Lofaro D, Cavedini P, Martino I, Bruni A, Sarica A, Mauro D, Merante G, Rossomanno I, Rizzuto M, Palmacci A, Aquino B, De Fazio P, Perna GR, Vanni E, Olivadese G, Conforti D, Arabia G, Quattrone A.

J Neurosci Methods. 2018 Jan 15;294:7-14. doi: 10.1016/j.jneumeth.2017.10.023. Epub 2017 Nov 1.

PMID:
29080669
50.

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology.

Bernabò P, Tebaldi T, Groen EJN, Lane FM, Perenthaler E, Mattedi F, Newbery HJ, Zhou H, Zuccotti P, Potrich V, Shorrock HK, Muntoni F, Quattrone A, Gillingwater TH, Viero G.

Cell Rep. 2017 Oct 24;21(4):953-965. doi: 10.1016/j.celrep.2017.10.010.

Supplemental Content

Loading ...
Support Center